ProTHESIS Scientific, LLC
Biotechnology - Philadelphia, Pennsylvania, United States
ProTHESIS Scientific, LLC Employees
ProTHESIS Scientific, LLC Details
ProTHESIS Scientific is set to disrupt and revive the Pharmaceutical, Biotechnology, and Medical Device Industry by addressing its most dire need: Increased Investment Opportunity at Reduced Cost and Time!We're on an unsustainable path, where the cost of drug development is growing enormously, as well as the costs of the new medicines. We need to do something now, to make the entire process less costly and more efficient." – Dr. Scott Gottlieb, 23rd Commissioner of FDA "Unless pharma can start to reduce R&D costs – and time – ROI will eventually fall to levels that threaten the sector's viability." - Ernst & Young, Biotechnology Report 2017It is currently estimated that the cost to bring a new drug to market is approximately $2.6 Billion and $1.3 Billion of that is spent in the research and development (non-clinical) phase of the process. – TCSDD and J.A.M.A.ServiceProTHESIS Scientific is an externally operated R&D commercialization service that is fully integrated into the customer's R&D environment to provide systems, technology, and specialized industry expertise that are vitally necessary to open the pipeline to investment opportunity in the FDA regulated Pharmaceutical industry. The impact of R&D is estimated to be between 33% and 43% of the overall development cost and 30% – 40% of overall development time. ProTHESIS Scientific Reduces direct cost by 15%, Accelerates development by 20% Guarantees customers will not have an IND hold
ProTHESIS Scientific, LLC Technologies
Hosting
Blue Host